Xtant Medical, Inc., a prominent player in the medical device industry, is headquartered in the United States, with significant operations across various regions. Founded in 2004, the company has established itself as a leader in the development of innovative solutions for spinal surgery and orthopaedics. Xtant Medical's core offerings include advanced spinal implants and regenerative medicine products, distinguished by their commitment to quality and patient outcomes. The company has achieved notable milestones, including strategic acquisitions that have expanded its product portfolio and market reach. With a strong focus on research and development, Xtant Medical continues to enhance its position in the competitive landscape, delivering unique solutions that address the evolving needs of healthcare professionals and patients alike.
How does Xtant Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Xtant Medical, Inc.'s score of 5 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Xtant Medical, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is a current subsidiary of Xtant Medical Holdings, Inc., which may influence its climate commitments and reporting practices. As of now, Xtant Medical has not established any documented reduction targets or initiatives related to the Science Based Targets initiative (SBTi) or other climate pledges. This lack of specific targets suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the absence of emissions data and reduction commitments, it is essential for Xtant Medical to consider implementing robust sustainability practices and setting measurable targets to align with industry standards and expectations. This would not only enhance their environmental performance but also contribute positively to the broader climate action efforts within the medical device sector.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Xtant Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.